Similar induction of IDO1 also appears to occur in patients, as indicated by the elevation of systemic kynurenine-to-tryptophan ratios in α-PD-1-treated sarcoma, melanoma and renal cell carcinoma patients (334, 335). This evidence concerns the gene IDO1 and melanoma.